TGF beta Activation
Transforming growth factor beta (TGF-
TGF-β activation
[edit]Although TGF-
TGF-β latency (latent TGF-β complex)
[edit]All three TGF
In most cases, before the LLC is secreted, the TGF-
There are four different LTBP isoforms known, LTBP-1, LTBP-2, LTBP-3 and LTBP-4.[13] Mutation or alteration of LAP or LTBP can result in improper TGF-
Integrin-independent TGF-β activation
[edit]- Activation by protease and metalloprotease
Plasmin and a number of Matrix metalloproteinases (MMP) play a key role in promoting tumor invasion and tissue remodeling by inducing proteolysis of several ECM components.[5] The TGF-
- Activation by pH
Acidic conditions can denature the LAP. Treatment of the medium with extremes of pH (1.5 or 12) resulted in significant activation of TGF beta as shown by radio-receptor assays, while mild acid treatment (pH 4.5) yielded only 20-30% of the competition achieved by pH 1.5.[16]
- Activation reactive oxygen species (ROS)
The LAP structure is important to maintain its function. Structure modification of the LAP can lead to disturbing the interaction between LAP and TGF-
- Activation by thrombospondin-1
Thrombospondin-1 (TSP-1) is a matricellular glycoprotein found in plasma of healthy patients with levels in the range of 50–250 ng/ml.[17] TSP-1 levels are known to increase in response to injury and during development.[18] TSP-1 activates latent TGF-beta [19] by forming direct interactions with the latent TGF-
Activation by Alpha(V) containing integrins
[edit]The general theme of integrins to participate in latent TGF-
- Conformation change mechanism pathway (without proteolysis)
- Integrin protease-dependent activation mechanism
Because MMP-2 and MMP-9 can activate TGF-
References
[edit]- ^ Roberts, A.B. and Sporn, M.B., 1990. The transforming growth factor
β s. In: Sporn, M.B. and Roberts, A.B., Editors, 1990. Peptides, Growth Factors and Their Receptors Part I, Springer-Verlag, Berlin, pp. 419–472, - ^ Yue, J; Mulder, KM (2001). "Transforming growth factor-beta signal transduction in epithelial cells". Pharmacol Ther. 91 (1): 1–34. doi:10.1016/s0163-7258(01)00143-7. PMID 11707292.
- ^ a b c d e f Annes, J.P.; Munger, J.S.; Rifkin, D.B. (2003). "Making sense of latent TGF
β activation". J. Cell Sci. 116 (2): 217–224. doi:10.1242/jcs.00229. PMID 12482908. - ^ P. ten Dijke and C.S. Hill, New insights into TGF-
β -Smad signalling, Trends Biochem Sci 29 (2004), pp. 265–273 - ^ a b Stetler-Stevenson, W.G.; Aznavoorian, S.; Liotta, L.A. (1993). "Tumor cell interactions with the extracellular matrix during invasion and metastasis". Annu. Rev. Cell Biol. 9: 541–573. doi:10.1146/annurev.cb.09.110193.002545. PMID 8280471.
- ^ a b Barcellos-Hoff, M. H.; Dix, T. A. (1996). "Redox-mediated activation of latent transforming growth factor-beta 1". Molecular Endocrinology. 10 (9): 1077–1083. doi:10.1210/mend.10.9.8885242. PMID 8885242.
- ^ Wipff, P.-J.; Hinz, B. (2008). "Integrins and the activation of latent transforming growth factor [beta]1 - An intimate relationship". European Journal of Cell Biology. 87 (8–9): 601–615. doi:10.1016/j.ejcb.2008.01.012. PMID 18342983.
- ^ a b c Yu, Q.; Stamenkovic, I. (2000). "Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis". Genes Dev. 14 (2): 163–176. doi:10.1101/gad.14.2.163. PMC 316345. PMID 10652271.
- ^ a b Taipale, J.; Miyazono, K.; Heldin, C. H.; Keski-Oja, J. (1994). "Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein". J. Cell Biol. 124 (1–2): 171–181. doi:10.1083/jcb.124.1.171. PMC 2119892. PMID 8294500.
- ^ Derynck, R.; Jarrett, J. A.; Chen, E. Y.; Eaton, D. H.; Bell, J. R.; Assoian, R. K.; Roberts, A. B.; Sporn, M. B.; Goeddel, D. V. (1985). "Human transforming growth factor-
β complementary DNA sequence and expression in normal and transformed cells". Nature. 316 (6030): 701–705. Bibcode:1985Natur.316..701D. doi:10.1038/316701a0. PMID 3861940. - ^ Rifkin, D. B. (2005). "Latent transforming growth factor-
β (TGF-β ) binding proteins: orchestrators of TGF-β availability". J. Biol. Chem. 280 (9): 7409–7412. doi:10.1074/jbc.r400029200. PMID 15611103. - ^ Dubois, C. M.; Laprise, M. H.; Blanchette, F.; Gentry, L. E.; Leduc, R. (1995). "Processing of transforming growth factor
β 1 precursor by human furin convertase". J. Biol. Chem. 270 (18): 10618–10624. doi:10.1074/jbc.270.18.10618. PMID 7737999. - ^ Saharinen, J.; Hyytiäinen, M.; Taipale, J.; Keski-Oja, J. (1999). "Latent transforming growth factor-beta binding proteins (LTBPs) structural extracellular matrix proteins for targeting TGF-beta action". Cytokine Growth Factor Review. 10 (2): 99–117. doi:10.1016/s1359-6101(99)00010-6. PMID 10743502.
- ^ Sterner-Kock, A.; Thorey, I. S.; Koli, K.; Wempe, F.; Otte, J.; Bangsow, T.; Kuhlmeier, K.; Kirchner, T.; Jin, S.; Keski-Oja, J.; et al. (2002). "Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer". Genes Dev. 16 (17): 2264–2273. doi:10.1101/gad.229102. PMC 186672. PMID 12208849.
- ^ Saharinen, J.; Keski-Oja, J. (2000). "Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta". Mol. Biol. Cell. 11 (8): 2691–2704. doi:10.1091/mbc.11.8.2691. PMC 14949. PMID 10930463.
- ^ Lyons, R. M.; Keski-Oja, J.; Moses, H. L. (1988). "Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium". J. Cell Biol. 106 (5): 1659–1665. doi:10.1083/jcb.106.5.1659. PMC 2115066. PMID 2967299.
- ^ Booth, W.J.; Berndt, M.C. (1987). "Thrombospondin in clinical disease states". Semin. Thromb. Hemostasis. 13 (3): 298–306. doi:10.1055/s-2007-1003505. PMID 3317840.
- ^ Raugi, R.J.; Olerud, J.E.; Gown, A.M. (1987). "Thrombospondin in early human wound tissue". J. Invest. Dermatol. 89 (6): 551–554. doi:10.1111/1523-1747.ep12461198. PMID 3680981.
- ^ Schultz-Cherry, S.; Murphy-Ullrich, J. E. (1993). "Thrombospondin causes activation of latent transforming growth factor- beta secreted by endothelial cells by a novel mechanism". J. Cell Biol. 122 (4): 923–932. doi:10.1083/jcb.122.4.923. PMC 2119591. PMID 8349738.
- ^ Murphy-Ullrich, J. E.; Poczatek, M. (2000). "Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology". Cytokine Growth Factor Rev. 11 (1–2): 59–69. doi:10.1016/s1359-6101(99)00029-5. PMID 10708953.
- ^ Huang, X.Z.; Wu, J.F.; Cass, D.; Erle, D.J.; Corry, D.; Young, S.G.; Farese Jr, R.V.; Sheppard, D. (1996). "Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin". J. Cell Biol. 133 (4): 921–928. doi:10.1083/jcb.133.4.921. PMC 2120829. PMID 8666675.
- ^ Bader, B.L.; Rayburn, H.; Crowley, D.; Hynes, R.O. (1998). "Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins". Cell. 95 (4): 507–519. doi:10.1016/s0092-8674(00)81618-9. PMID 9827803.
- ^ Shull, M.M.; Ormsby, I.; Kier, A.B.; Pawlowski, S.; Diebold, R.J.; Yin, M.; Allen, R.; Sidman, C.; Proetzel, G.; Calvin, D.; Annunziata, N.; Doetschman, T. (1992). "Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease". Nature. 359 (6397): 693–699. Bibcode:1992Natur.359..693S. doi:10.1038/359693a0. PMC 3889166. PMID 1436033.
- ^ a b Wipff, P.-J.; Hinz, B. (2008). "Integrins and the activation of latent transforming growth factor [beta]1 - An intimate relationship". European Journal of Cell Biology. 87 (8–9): 601–615. doi:10.1016/j.ejcb.2008.01.012. PMID 18342983.
- ^ Mamuya, F. A.; Duncan, M. K. (2012). "Alpha V integrins and TGF-beta-induced EMT: a circle of regulation". J Cell Mol Med. 16 (3): 445–55. doi:10.1111/j.1582-4934.2011.01419.x. PMC 3290750. PMID 21883891.
- ^ Munger, J.S.; Harpel, J.G.; Giancotti, F.G.; Rifkin, D.B. (1998). "Interactions between growth factors and integrins: latent forms of transforming growth factor-
β are ligands for the integrinα vβ 1". Mol. Biol. Cell. 9 (9): 2627–2638. doi:10.1091/mbc.9.9.2627. PMC 25536. PMID 9725916. - ^ Munger, J. S.; Huang, X.; Kawakatsu, H.; Griffiths, M. J.; Dalton, S. L.; Wu, J.; Pittet, J. F.; Kaminski, N.; Garat, C.; Matthay, M. A.; et al. (1999). "The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis". Cell. 96 (3): 319–328. doi:10.1016/S0092-8674(00)80545-0. PMID 10025398.
- ^ Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., Karlsson, S. (1993) Transforming growth factor
β 1 null mutation in mice causes - ^ Taylor, Andrew W. (2009). "Review of the activation of TGF-
β in immunity". Journal of Leukocyte Biology. 85 (1): 29–33. doi:10.1189/jlb.0708415. PMC 3188956. PMID 18818372. - ^ Mu, D.; Cambier, S.; Fjellbirkeland, L.; Baron, J.L.; Munger, J.S.; Kawakatsu, H.; Sheppard, D.; Broaddus, V.C.; Nishimura, S.L. (2002). "the integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1". J. Cell Biol. 157 (3): 493–507. doi:10.1083/jcb.200109100. PMC 2173277. PMID 11970960.